Saturday, January 30, 2027
77 days away
Drug Information
- Drug Name
- Joenja →
- Application Type
- Priority Review
Filing Details
- Company
- Pharming Group N.V.
- Stock Ticker
- PHAR
- SEC CIK
- 0001828316
- Source
- SEC filing →
Active Phase 3 Trials
Loading trials...
No active Phase 3 trials found in our database.
What is a PDUFA Date?
A PDUFA (Prescription Drug User Fee Act) date is the FDA's target deadline to complete review of a drug application. The FDA aims to make an approval decision by this date.
- Standard Review: 10 months from filing acceptance
- Priority Review: 6 months from filing acceptance
- Possible Outcomes: Approval, Complete Response Letter (CRL), or extension
Track All FDA Decisions
View all upcoming PDUFA dates and AdCom meetings on our FDA Calendar.
View FDA Calendar →Data sourced from SEC EDGAR filings. Last updated: 2026-10-27. Report an issue